Dr. Biswaroop’s appeal to Govt of India
Topic: Stop prescribing Anti-Malaria drug
With reference to Ministry of Health & Family Welfare & Directorate General of Health Services (EMR Division) the guideline on Clinical Management of COVID-19 as is displayed in “MoHFw.gov.in” as on 20th April – 2020, it recommends the following medicine for the treatment and prevention of COVID-19
1) Hydroxychloroquine in combination with Azithromycin as treatment
2) Hydroxychloroquine for Prevention of COVID-19
The use of the above anti malarial drugs for the treatment of COVID-19 should be halted with immediate effect because of the following references:
- There is insufficient evidence to determine whether Hydroxychloroquine are safe and effective treatment for COVID-19
- CloroCovid 19 study (clinical trial started on 23rd March 2020 aimed to finish on 31st August 2020, was halted prematurely because of potential safety hazards.
- Guwahati doctor Dr Utpal Barman, 44yr old on HCQ(hydroxychloroquine) died of cardiac arrest on 28th March 2020. He was on Hydroxychloroquine as a preventive medication. Reference Link 1, Reference link 2 & Reference link 3
- According to ACC, 29th March 2020 HCQ- Azithromycin treatment in COVID-19 may cause Ventricular Arrhythmia, increasing the mortality risk.
- According to the study “ a retrospective analysis on outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 “ posted April 23, 2020, the rate of death in hydroxychloroquine, hyroxychloroquine with azithromycin and no hydroxychloroquine groups were 27.8%, 22.1% and 11.4% respectively